| DNTHDianthus Therapeutics, Inc. /DE/ | 560,308 | $47.0M |
| BBIOBridgeBio Pharma, Inc. | 432,014 | $32.1M |
| BMYBRISTOL MYERS SQUIBB CO | 420,727 | $25.5M |
| SNDXSyndax Pharmaceuticals Inc | 1,043,670 | $24.4M |
| GILDGILEAD SCIENCES, INC. | 163,905 | $22.8M |
| TERNTerns Pharmaceuticals, Inc. | 409,031 | $21.6M |
| DFTXDefinium Therapeutics Inc. | 1,037,984 | $19.6M |
| SLNOSOLENO THERAPEUTICS INC | 577,808 | $19.3M |
| RAREUltragenyx Pharmaceutical Inc. | 850,797 | $17.8M |
| INCYIncyte Corp. | 182,101 | $17.1M |
| CYTKCYTOKINETICS INC | 215,501 | $14.2M |
| CRVSCorvus Pharmaceuticals, Inc. | 891,933 | $13.0M |
| GPCRStructure Therapeutics Inc. | 255,379 | $12.3M |
| MLYSMineralys Therapeutics, Inc. | 439,041 | $11.9M |
| MANEVeradermics Incorporated | 173,582 | $11.0M |
| ADPTAdaptive Biotechnologies Corp | 722,784 | $10.0M |
| KALVKalVista Pharmaceuticals, Inc. | 426,551 | $8.6M |
| QUREuniQure N.V. | 491,116 | $8.0M |
| IRONDisc Medicine, Inc. | 122,978 | $7.9M |
| SEPNSepterna, Inc. | 294,360 | $7.1M |
| ABVXAbivax SA | 47,193 | $5.3M |
| DYNDyne Therapeutics, Inc. | 282,954 | $5.1M |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | 62,019 | $3.2M |
| TARAProtara Therapeutics, Inc. | 580,024 | $3.0M |
| PHATPhathom Pharmaceuticals, Inc. | 247,767 | $2.8M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 83,554 | $2.7M |
| TYRATyra Biosciences, Inc. | 67,285 | $2.6M |
| IMCRImmunocore Holdings plc | 84,352 | $2.5M |
| ATAIAtai Beckley N.V. | 196,858 | $697K |
| SNSESensei Biotherapeutics, Inc. | 14,718 | $464K |